Shopping Cart 0
Cart Subtotal
AED 0

Lannett Co Inc (LCI) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376

Details

Lannett Co Inc (LCI)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lannett Co Inc (Lannett) is a pharmaceutical company. It develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms. The company offers generic pharmaceuticals for medical indications such as antibiotic, cardiovascular, central nervous systems, gallstone, gastrointestinal, glaucoma, gout, migraine, muscle relaxant, obesity, pain management, respiratory, thyroid deficiency and urinary. Lannett also offers laboratory services, product formulation and development services, granulation, blending, encapsulation, compression, coating and packaging solid dosage forms. The company sells pharmaceutical products across the US to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private-label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations and health maintenance organizations. Lannett is headquartered in Philadelphia, Pennsylvania, the US.

Lannett Co Inc Key Recent Developments

Nov 06,2019: Lannett announces fiscal 2020 first-quarter financial results

Aug 29,2019: Lannett agrees to distribute Posaconazole tablets in US

Aug 27,2019: Lannett enters into advisory services agreement with strategic alliance partner

Aug 27,2019: Lannett announces fiscal 2019 fourth-quarter, full-year financial results; issues guidance for fiscal 2020

Aug 01,2019: Lannett appoints John Kozlowski CFO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Lannett Co Inc-Key Facts

Lannett Co Inc-Key Employees

Lannett Co Inc-Key Employee Biographies

Lannett Co Inc-Major Products and Services

Lannett Co Inc-History

Lannett Co Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Lannett Co Inc-Business Description

Lannett Co Inc-Corporate Strategy

Lannett Co Inc-SWOT Analysis

SWOT Analysis-Overview

Lannett Co Inc-Strengths

Lannett Co Inc-Weaknesses

Lannett Co Inc-Opportunities

Lannett Co Inc-Threats

Lannett Co Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Lannett Co Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Nov 06, 2019: Lannett announces fiscal 2020 first-quarter financial results

Aug 29, 2019: Lannett agrees to distribute Posaconazole tablets in US

Aug 27, 2019: Lannett enters into advisory services agreement with strategic alliance partner

Aug 27, 2019: Lannett announces fiscal 2019 fourth-quarter, full-year financial results; issues guidance for fiscal 2020

Aug 01, 2019: Lannett appoints John Kozlowski CFO

May 24, 2019: Lannett announces CFO retirement

May 23, 2019: Lannett Company names Melissa V. Rewolinski, PhD, to Board Of Directors

May 13, 2019: US states file lawsuit against 20 drugmakers accused of price-fixing

May 06, 2019: Lannett announces fiscal 2019 third-quarter financial results

Mar 21, 2019: Lannett purchases USD 24 million of term loans in open market transactions

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Lannett Co Inc, Performance Chart (2015-2019)

Lannett Co Inc, Ratio Charts

Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Lannett Co Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Lannett Co Inc, Key Facts

Lannett Co Inc, Key Employees

Lannett Co Inc, Key Employee Biographies

Lannett Co Inc, Major Products and Services

Lannett Co Inc, History

Lannett Co Inc, Other Locations

Lannett Co Inc, Subsidiaries

Lannett Co Inc, Key Competitors

Lannett Co Inc, Ratios based on current share price

Lannett Co Inc, Annual Ratios

Lannett Co Inc, Annual Ratios (Cont...1)

Lannett Co Inc, Annual Ratios (Cont...2)

Lannett Co Inc, Interim Ratios

Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Lannett Co Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Lannett Co Inc , SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Sandoz Inc

Pharming Group NV

Par Pharmaceutical Holdings Inc

Mylan Delaware Inc.

Mallinckrodt LLC

GlaxoSmithKline Plc

Dr. Reddy's Laboratories Inc

Aurobindo Pharma USA Inc

Company Profile

Company Profile Title

Lannett Co Inc (LCI)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lannett Co Inc (Lannett) is a pharmaceutical company. It develops, manufactures and distributes generic prescription pharmaceutical products in tablet, capsule and oral liquid forms. The company offers generic pharmaceuticals for medical indications such as antibiotic, cardiovascular, central nervous systems, gallstone, gastrointestinal, glaucoma, gout, migraine, muscle relaxant, obesity, pain management, respiratory, thyroid deficiency and urinary. Lannett also offers laboratory services, product formulation and development services, granulation, blending, encapsulation, compression, coating and packaging solid dosage forms. The company sells pharmaceutical products across the US to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private-label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations and health maintenance organizations. Lannett is headquartered in Philadelphia, Pennsylvania, the US.

Lannett Co Inc Key Recent Developments

Nov 06,2019: Lannett announces fiscal 2020 first-quarter financial results

Aug 29,2019: Lannett agrees to distribute Posaconazole tablets in US

Aug 27,2019: Lannett enters into advisory services agreement with strategic alliance partner

Aug 27,2019: Lannett announces fiscal 2019 fourth-quarter, full-year financial results; issues guidance for fiscal 2020

Aug 01,2019: Lannett appoints John Kozlowski CFO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Lannett Co Inc-Key Facts

Lannett Co Inc-Key Employees

Lannett Co Inc-Key Employee Biographies

Lannett Co Inc-Major Products and Services

Lannett Co Inc-History

Lannett Co Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Lannett Co Inc-Business Description

Lannett Co Inc-Corporate Strategy

Lannett Co Inc-SWOT Analysis

SWOT Analysis-Overview

Lannett Co Inc-Strengths

Lannett Co Inc-Weaknesses

Lannett Co Inc-Opportunities

Lannett Co Inc-Threats

Lannett Co Inc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Lannett Co Inc, Recent Deals Summary

Section 5-Company's Recent Developments

Nov 06, 2019: Lannett announces fiscal 2020 first-quarter financial results

Aug 29, 2019: Lannett agrees to distribute Posaconazole tablets in US

Aug 27, 2019: Lannett enters into advisory services agreement with strategic alliance partner

Aug 27, 2019: Lannett announces fiscal 2019 fourth-quarter, full-year financial results; issues guidance for fiscal 2020

Aug 01, 2019: Lannett appoints John Kozlowski CFO

May 24, 2019: Lannett announces CFO retirement

May 23, 2019: Lannett Company names Melissa V. Rewolinski, PhD, to Board Of Directors

May 13, 2019: US states file lawsuit against 20 drugmakers accused of price-fixing

May 06, 2019: Lannett announces fiscal 2019 third-quarter financial results

Mar 21, 2019: Lannett purchases USD 24 million of term loans in open market transactions

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Lannett Co Inc, Performance Chart (2015-2019)

Lannett Co Inc, Ratio Charts

Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Lannett Co Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Lannett Co Inc, Key Facts

Lannett Co Inc, Key Employees

Lannett Co Inc, Key Employee Biographies

Lannett Co Inc, Major Products and Services

Lannett Co Inc, History

Lannett Co Inc, Other Locations

Lannett Co Inc, Subsidiaries

Lannett Co Inc, Key Competitors

Lannett Co Inc, Ratios based on current share price

Lannett Co Inc, Annual Ratios

Lannett Co Inc, Annual Ratios (Cont...1)

Lannett Co Inc, Annual Ratios (Cont...2)

Lannett Co Inc, Interim Ratios

Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Lannett Co Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Lannett Co Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Lannett Co Inc , SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Sandoz Inc

Pharming Group NV

Par Pharmaceutical Holdings Inc

Mylan Delaware Inc.

Mallinckrodt LLC

GlaxoSmithKline Plc

Dr. Reddy's Laboratories Inc

Aurobindo Pharma USA Inc